Abstract

Duloxetine is an antidepressant that exhibits its action by preventing the reuptake of serotonin and norepinephrine by neurons. In this analytical study, we developed two facile, sensitive methods for duloxetine analysis. Both methods rely on the formation of binary association complex between erythrosine-B and duloxetine in an acidic medium using spectrofluorimetric and resonance Rayleigh scattering (RRS) techniques. Spectrofluorimetric method simply uses the quenching property of the formed complex on the native fluorescence of erythrosine-B at an emission wavelength of 557.2 nm (λex = 528.6), while RRS is based on detecting the enhancement in the RRS signal at 357.2 nm. The proposed methods have been validated according to the International Conference on Harmonization guidelines. The approaches provide linear assay of duloxetine hydrochloride over 0.1–2.4 µg ml−1 and 0.2–2.0 µg ml−1 for spectrofluorimetric and RRS methods, respectively. Variables affecting methods and complex formation were studied and optimized. The limit of detection values were 0.03 and 0.056 µg ml−1 for spectrofluorimetric and RRS methods, respectively. Both approaches were applied with acceptable results for formulation analysis and evaluation of cymbatex capsule content uniformity.

Highlights

  • Duloxetine hydrochloride (DLX) is chemically named (+)-(S)-N-methyl-γ-(1-naphthyloxy)-2thiophenepropylamine hydrochloride

  • Xanthene dye as erythrosine-B dye is a popular reagent that is used in spectrophotometry, spectrofluorimetry and resonance Rayleigh scattering (RRS) [24,25,26,27,28]

  • The reaction is based on the formation of an association complex with the detected drug while the measurements are based on detecting the fluorescence intensity changes or improving the strength of the RRS spectrum

Read more

Summary

Introduction

Duloxetine hydrochloride (DLX) is chemically named (+)-(S)-N-methyl-γ-(1-naphthyloxy)-2thiophenepropylamine hydrochloride. DLX has no notable affinity for cholinergic, dopaminergic, adrenergic, histaminergic, glutamate, opioid or GABA receptors [1]. It is prescribed for the treatment of major depressive disorder, anxiety disorder management, fibromyalgia, peripheral neuropathic pain in diabetic patients or induced by chemotherapy [2,3], and stress urinary incontinence [4]. Because DLX has a basic centre (amino group), it can form an ion pair complex with erythrosine-B, permitting its assay by either RRS or spectrofluorimetric approaches. Two facile and sensitive methods were developed for the assay of DLX using erythrosine-B as a fluorescence or Rayleigh scattering probe

Apparatus
General assay procedure
Procedure for duloxetine hydrochloride assay in dosage forms
Results and discussion
Enlargement of molecular volume
Hydrophobic interface formation
Rigidity and molecular planarity effects
Experimental condition study
Buffer pH and volume
Erythrosine-B volume and diluting solvent
Linearity range and sensitivity
Accuracy and precision
Robustness
Dosage form application
Content uniformity testing
Molar ratio determination
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call